Completed
A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC
NCT05291689
- Conditions
- Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
- Locations
-
- Clinical Study Site Tampa, Florida, United States
- Clinical Study Site Lafayette, Louisiana, United States
- Clinical Study Site Freehold, New Jersey, United States
- Clinical Study Site Brooklyn, New York, United States